Eterna Therapeutics (ERNA) Institutional Ownership

$1.79
+0.05 (+2.87%)
(As of 04/26/2024 ET)

Institutional Ownership Changes (13F Filings) for Eterna Therapeutics (NASDAQ:ERNA)

Current
Institutional Ownership
Percentage
70.55%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$1.01M
Number of
Institutional Sellers
(last 12 months)
0
Get ERNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eterna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ERNA Institutional Buying and Selling by Quarter

Eterna Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2024Lake Street Advisors Group LLC520,996$933K0.1%N/A9.630%
1/30/2024Sippican Capital Advisors54,050$97K0.1%+92.3%0.999%
1/1/2024Vanguard Group Inc.24,898$54K0.0%+30.6%0.460%
10/24/2023Sippican Capital Advisors28,100$61K0.1%+30.1%0.519%
2/1/2023Cypress Point Wealth Management LLC94,375$304K0.5%N/A3.210%
1/31/2023 Naviter Wealth LLC79,621$387K0.1%N/A2.708%
(Data available from 1/1/2016 forward)

ERNA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ERNA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Eterna Therapeutics shares: Lake Street Advisors Group LLC ($933K), Naviter Wealth LLC ($387K), Cypress Point Wealth Management LLC ($304K), and Sippican Capital Advisors ($97K), Vanguard Group Inc. ($54K).Learn more on ERNA's institutional investors.

What percentage of Eterna Therapeutics stock is owned by institutional investors?

70.55% of Eterna Therapeutics stock is owned by institutional investors. Learn more on ERNA's institutional investor holdings.

Which institutional investors have been buying Eterna Therapeutics stock?

The following institutional investors have purchased Eterna Therapeutics stock in the last 24 months: Lake Street Advisors Group LLC ($521.00K), Cypress Point Wealth Management LLC ($94.38K), Naviter Wealth LLC ($79.62K), Sippican Capital Advisors ($32.45K), and Vanguard Group Inc. ($5.83K).

How much institutional buying is happening at Eterna Therapeutics?

Institutional investors have bought a total of 733,271 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions.


This page (NASDAQ:ERNA) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners